- Home
- NCNO vs SLNO Comparison
NCNO vs SLNO Comparison
Compare NCNO & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NCNO | SLNO |
|---|---|---|
| Founded | 2011 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.3B |
| IPO Year | 2022 | 2014 |
Fundamental Metrics
Financial Performance| Metric | NCNO | SLNO |
|---|---|---|
| Price | $17.42 | $52.84 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 16 | 9 |
| Target Price | $26.07 | ★ $83.00 |
| AVG Volume (30 Days) | 3.4M | ★ 6.2M |
| Earning Date | 05-27-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 115.15 | 108.90 |
| EPS | 0.05 | ★ 0.39 |
| Revenue | ★ $594,781,000.00 | $1,450,788.00 |
| Revenue This Year | $9.53 | $150.46 |
| Revenue Next Year | $8.97 | $50.37 |
| P/E Ratio | $348.50 | ★ $135.41 |
| Revenue Growth | 10.01 | ★ 138.82 |
| 52 Week Low | $13.80 | $29.43 |
| 52 Week High | $33.92 | $89.12 |
Technical Indicators
Market Signals| Indicator | NCNO | SLNO |
|---|---|---|
| Relative Strength Index (RSI) | 51.69 | 77.00 |
| Support Level | $13.80 | $48.91 |
| Resistance Level | $18.76 | $55.47 |
| Average True Range (ATR) | 0.76 | 0.12 |
| MACD | -0.08 | -0.39 |
| Stochastic Oscillator | 31.07 | 89.19 |
Price Performance
Historical ComparisonAbout NCNO nCino Inc.
Ncino Inc is a provider of cloud-based software for financial institutions. It is focused on developing the nCino Platform to transform commercial and small business lending for community and regional banks in the U.S. With the company's platform financial institutions can Operate More Intelligently, Improve Efficiency, Elevate Employee and Client Experiences, and Manage Risk and Compliance Continuously Rather Than Reactively. It has built and acquired technology, including SimpleNexus, DocFox, FullCircl, ILT, Visible Equity, FinSuite, and Sandbox Banking, to augment the nCino Platform's capabilities for mortgage lending, onboarding, account opening, indirect auto lending, and analytics and AI. The company operates as one operating segment.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.